Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Vishal C Kalel

Showing results (21-30 of 26) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 26 results.
European Journal of Medicinal Chemistry|July 5, 2023
Development of novel PEX5-PEX14 protein-protein interaction (PPI) inhibitors based on an oxopiperazine templateMonika Marciniak, Piotr Mróz, Valeria Napolitano, et al.
Biochimica Et Biophysica Acta. Molecular Cell Research|August 2, 2019
Evolutionary divergent PEX3 is essential for glycosome biogenesis and survival of trypanosomatid parasitesVishal C Kalel, Mengqiao Li, Stefan Gaussmann, et al.
European Journal of Medicinal Chemistry|August 1, 2025
Quantum mechanics-driven structure-activity relationship study of PEX5-PEX14 protein-protein interaction inhibitors based on a dibenzo[b,e]azepin-6(6H)-one scaffoldMichał Nowacki, Filipe Menezes, Emilia Pykacz, et al.
Journal of Chemical Information and Modeling|October 1, 2021
Computer-Aided Design and Synthesis of a New Class of PEX14 Inhibitors: Substituted 2,3,4,5-Tetrahydrobenzo[F][1,4]oxazepines as Potential New Trypanocidal AgentsRoberto Fino, Dominik Lenhart, Vishal C Kalel, et al.
European Journal of Medicinal Chemistry|October 4, 2022
Structure-based design, synthesis and evaluation of a novel family of PEX5-PEX14 interaction inhibitors against TrypanosomaValeria Napolitano, Piotr Mróz, Monika Marciniak, et al.
Journal of Medicinal Chemistry|December 21, 2019
Structure-Activity Relationship in Pyrazolo[4,3-<i>c</i>]pyridines, First Inhibitors of PEX14-PEX5 Protein-Protein Interaction with Trypanocidal ActivityMaciej Dawidowski, Vishal C Kalel, Valeria Napolitano, et al.
Pageof 3

Showing results (21-30 of 26) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 26 results.
European Journal of Medicinal Chemistry|July 5, 2023
Development of novel PEX5-PEX14 protein-protein interaction (PPI) inhibitors based on an oxopiperazine templateMonika Marciniak, Piotr Mróz, Valeria Napolitano, et al.
Biochimica Et Biophysica Acta. Molecular Cell Research|August 2, 2019
Evolutionary divergent PEX3 is essential for glycosome biogenesis and survival of trypanosomatid parasitesVishal C Kalel, Mengqiao Li, Stefan Gaussmann, et al.
European Journal of Medicinal Chemistry|August 1, 2025
Quantum mechanics-driven structure-activity relationship study of PEX5-PEX14 protein-protein interaction inhibitors based on a dibenzo[b,e]azepin-6(6H)-one scaffoldMichał Nowacki, Filipe Menezes, Emilia Pykacz, et al.
Journal of Chemical Information and Modeling|October 1, 2021
Computer-Aided Design and Synthesis of a New Class of PEX14 Inhibitors: Substituted 2,3,4,5-Tetrahydrobenzo[F][1,4]oxazepines as Potential New Trypanocidal AgentsRoberto Fino, Dominik Lenhart, Vishal C Kalel, et al.
European Journal of Medicinal Chemistry|October 4, 2022
Structure-based design, synthesis and evaluation of a novel family of PEX5-PEX14 interaction inhibitors against TrypanosomaValeria Napolitano, Piotr Mróz, Monika Marciniak, et al.
Journal of Medicinal Chemistry|December 21, 2019
Structure-Activity Relationship in Pyrazolo[4,3-<i>c</i>]pyridines, First Inhibitors of PEX14-PEX5 Protein-Protein Interaction with Trypanocidal ActivityMaciej Dawidowski, Vishal C Kalel, Valeria Napolitano, et al.
Pageof 3